SARGENT INVESTMENT GROUP, LLC – SPDR S&P Biotech ETF Transaction History
SARGENT INVESTMENT GROUP, LLC portfolio value:
$446,000
portfolio value
SARGENT INVESTMENT GROUP, LLC quarter portfolio value change:
+6.80%
quarter
SPDR S&P Biotech ETF 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +24.42% | 1.06K shares | 124K | $79.32 | 5.4K |
| Q2 2022 | share | Increase | +6.11% | 250 shares | -46K | $74.27 | 4.34K |
| Q1 2022 | share | Increase | +12.67% | 460 shares | -38K | $89.88 | 4.09K |
| Q4 2021 | share | Increase | +2.54% | 90 shares | -39K | $113.24 | 3.63K |
| Q3 2021 | share | 0.00% | 0 shares | -34K | $125.71 | 3.54K | |
| Q2 2021 | share | 0.00% | 0 shares | -1K | $135.4 | 3.54K | |
| Q1 2021 | share | 0.00% | 0 shares | -18K | $135.65 | 3.54K | |
| Q4 2020 | share | 0.00% | 0 shares | 104K | $140.74 | 3.54K | |
| Q3 2020 | share | Decrease | -7.81% | -300 shares | -38K | $111.27 | 3.54K |
| Q2 2020 | share | Increase | +6.22% | 225 shares | 152K | $111.7 | 3.84K |
| Q1 2020 | share | 0.00% | 0 shares | -64K | $77.26 | 3.61K | |
| Q4 2019 | share | 0.00% | 0 shares | 68K | $94.88 | 3.61K | |
| Q3 2019 | share | 0.00% | 0 shares | -41K | $76.07 | 3.61K | |
| Q2 2019 | share | 0.00% | 0 shares | -10K | $87.5 | 3.61K | |
| Q1 2019 | share | 0.00% | 0 shares | 68K | $90.32 | 3.61K | |
| Q4 2018 | share | Increase | 0.00% | 3.61K shares | 259K | $71.58 | 3.61K |